Many clinical studies have shown that TOPK is a predicted marker of poor prognosis in patients with a variety of tumors, such as colorectal cancer [24], gastric carcinoma [25], and ovarian cancer [26]. The gene discussed is PBK; the disease is ovarian cancer.